Výsledky vyhledávání - Jean‐Christophe Eymard

  • Zobrazuji výsledky 1 - 9 z 9
Upřesnit hledání
  1. 1
    Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer

    Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer Autor Judith Passildas, Jean‐Christophe Eymard, Mélanie Pouget, Fabrice Kwiatkowski, Isabelle Van Praagh, L. Savareux, Marc Atger, Xavier Durando, Catherine Abrial, Damien Richard, Angeline Ginzac, Émilie Thivat, Brigitte Monange, P. Chollet, Hakim Mahammedi

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer

    Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer Autor Isabelle Treilleux, Mónica Arnedos, Claire Cropet, Q. Wang, Jean‐Marc Ferrero, Sophie Abadie‐Lacourtoisie, Christelle Lévy, Éric Legouffe, Alain Lortholary, Éric Pujade-Lauraine, Anne-Véronique Bourcier, Jean-Christophe Eymard, D. Spaëth, Thomas Bachelot

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

    Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breas... Autor Thomas Bachelot, C. Bourgier, Claire Cropet, Isabelle Ray‐Coquard, Jean-­Marc Ferrero, Gilles Freyer, Sophie Abadie‐Lacourtoisie, Jean‐Christophe Eymard, Marc Debled, Dominique Spaëth, Éric Legouffe, Djelila Allouache, Claude El Kouri, Éric Pujade-Lauraine

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

    Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer Autor Ronald de Wit, Johann S. de Bono, Cora N. Sternberg, Karim Fizazi, Bertrand Tombal, Christian Wülfing, Gero Kramer, Jean‐Christophe Eymard, Aristotelis Bamias, Joan Carles, Roberto Iacovelli, Bohuslav Melichar, Ásgerður Sverrisdóttir, Christine Théodore, Susan Feyerabend, Carole Hélissey, Ayse Ӧzatılgan, Christine Geffriaud-Ricouard, Daniel Castellano

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial

    Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemothera... Autor Cora N. Sternberg, Daniel P. Petrylak, Oliver Sartor, J. Alfred Witjes, Tomasz Demkow, Jean-­Marc Ferrero, Jean-Christophe Eymard, S. Falcon, Fabio Calabrò, Nicholas D. James, I. Bodrogi, Peter Harper, Manfred Wirth, William Berry, Michael E. Petrone, Thomas J. McKearn, Mojtaba Noursalehi, Martine George, Marcel Rozencweig

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial

    Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial Autor Karim Fizazi, Lance C. Pagliaro, Agnès Laplanche, Aude Fléchon, J. Mardiak, Lionnel Geoffrois, Pierre Kerbrat, Christine Chevreau, R. Delva, Frédéric Rolland, Christine Théodore, Guilhem Roubaud, Gwénaëlle Gravis, Jean-Christophe Eymard, Jean-Pierre Malhaire, Claude Linassier, Muriel Habibian, Anne-Laure Martin, Florence Journeau, Mária Rečková, Christopher J. Logothetis, Stéphane Culine

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort

    Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort Autor Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, Florence Dalenc, Audrey Mailliez, Christelle Lévy, Véronique D’Hondt, Marc Debled, Thomas Vermeulin, Bruno Coudert, Christophe Perrin, Anthony Gonçalvès, Lionel Uwer, Jean-­Marc Ferrero, Jean‐Christophe Eymard, Thierry Petit, Marie‐Ange Mouret‐Reynier, Anne Patsouris, T. Guesmia, Thomas Bachelot, Mathieu Robain, Paul Cottu

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

    Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre... Autor Karim Fizazi, Gero Kramer, Jean-Christophe Eymard, Cora N. Sternberg, Johann S. de Bono, Daniel Castellano, Bertrand Tombal, Christian Wülfing, Michalis Liontos, Joan Carles, Roberto Iacovelli, Bohuslav Melichar, Ásgerður Sverrisdóttir, Christine Théodore, Susan Feyerabend, Carole Hélissey, Stéphane Oudard, Gaetano Facchini, Elizabeth M. Poole, Ayse Ӧzatılgan, Christine Geffriaud-Ricouard, Samira Bensfia, Ronald de Wit

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

    Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial Autor Matthew R. Smith, Howard I. Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, Kim N., Fred Saad, Olof Ståhl, David Olmos, Daniel C. Danila, Gary Mason, Byron M. Espina, Xin Zhao, Karen A. Urtishak, Peter Francis, Angela Lopez‐Gitlitz, Karim Fizazi, Francis Parnis, Anthony M. Joshua, Lisa G. Horvath, Christopher Steer, Gavin Marx, Shahneen Sandhu, Howard Gurney, T. J. Ferguson, Siska Van Bruwaene, Daisy Luyten, Peter Schatteman, Nicolaas Lumen, Luc Dirix, Jean‐Charles Goeminne, Thierry Gil, Emmanuel Seront, Christof Vulsteke, Celio Kussumoto, Fábio Franke, Fabrício Augusto Martinelli de Oliveira, Andrea Juliana Gomes, Hélio Pinczowski, Daniel D’Almeida Preto, Luis Eduardo Rosa Zucca, Giuliano Santos Borges, André M. Murad, Fred Saad, Kim N., Yves Fradet, Neil Fleshner, Urban Emmenegger, Klaus Brasso, Karim Fizazi, Stéphane Culine, Antoine Thiery-Vuillemin, Florence Joly, Aude Fléchon, Werner Hilgers, Jean‐Christophe Eymard, Delphine Borchiellini, Philippe Barthélémy, Raanan Berger, Raya Leibowitz‐Amit, Wilmosh Mermershtain, Keren Rouvinov, Avivit Peer, Svetlana Kovel, Avishay Sella, Martijn P. Lolkema, Alfonsus Johannes Maria van den Eertwegh, Johannes Voortman, Maureen J.B. Aarts, Jourik A. Gietema, Choung‐Soo Kim, Young Deuk Choi, Byung Ha Chung, Rustem Gafanov, Evgeniy Kopyltsov, Evgeny A. Usynin, Joan Carles, Begoña Mellado, Pablo Maroto, Jesús García-Donás, Juan F. Rodríguez-Moreno, Ignacio Durán, Begoña Pérez-Valderrama, Elena Castro, David Olmos, María José Méndez-Vidal, D. Lorente Estellés, Regina Gironés Sarrió, José Muñoz-Langa, Urbano Anido Herranz, Javier Puente, E.A. Castellanos Abella, Martin Hellström, Anders Widmark, Ingela Franck Lissbrant, Åsa Jellvert, Cecilia Külich, René Blom

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: